Evolving therapies for atopic dermatitis: Bridging guidelines and practice
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin condition characterised by dysregulated type 2 immune responses, skin barrier dysfunction and intense pruritus (itching). The disease burden of AD is substantial, affecting at least 171 million individuals worldwide in 2019, represent...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academy of Medicine Singapore
2024-11-01
|
| Series: | Annals, Academy of Medicine, Singapore |
| Online Access: | https://annals.edu.sg/evolving-therapies-for-atopic-dermatitis-bridging-guidelines-and-practice/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846143115722752000 |
|---|---|
| author | Pawinee Rerknimitr |
| author_facet | Pawinee Rerknimitr |
| author_sort | Pawinee Rerknimitr |
| collection | DOAJ |
| description |
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin condition characterised by dysregulated type 2 immune responses, skin barrier dysfunction and intense pruritus (itching). The disease burden of AD is substantial, affecting at least 171 million individuals worldwide in 2019, representing 2.23% of the global population.1 Among skin diseases, AD ranks highest in disease burden, as measured by disability-adjusted life-years (DALYs).2 Its profound impact on patients’ quality of life, along with significant economic burdens, underscores its status as a major healthcare challenge. |
| format | Article |
| id | doaj-art-0e4ad21b52df47f38f26992728ec0693 |
| institution | Kabale University |
| issn | 2972-4066 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Academy of Medicine Singapore |
| record_format | Article |
| series | Annals, Academy of Medicine, Singapore |
| spelling | doaj-art-0e4ad21b52df47f38f26992728ec06932024-12-03T01:19:04ZengAcademy of Medicine SingaporeAnnals, Academy of Medicine, Singapore2972-40662024-11-01531164164310.47102/annals-acadmedsg.2024355Evolving therapies for atopic dermatitis: Bridging guidelines and practicePawinee Rerknimitr Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin condition characterised by dysregulated type 2 immune responses, skin barrier dysfunction and intense pruritus (itching). The disease burden of AD is substantial, affecting at least 171 million individuals worldwide in 2019, representing 2.23% of the global population.1 Among skin diseases, AD ranks highest in disease burden, as measured by disability-adjusted life-years (DALYs).2 Its profound impact on patients’ quality of life, along with significant economic burdens, underscores its status as a major healthcare challenge.https://annals.edu.sg/evolving-therapies-for-atopic-dermatitis-bridging-guidelines-and-practice/ |
| spellingShingle | Pawinee Rerknimitr Evolving therapies for atopic dermatitis: Bridging guidelines and practice Annals, Academy of Medicine, Singapore |
| title | Evolving therapies for atopic dermatitis: Bridging guidelines and practice |
| title_full | Evolving therapies for atopic dermatitis: Bridging guidelines and practice |
| title_fullStr | Evolving therapies for atopic dermatitis: Bridging guidelines and practice |
| title_full_unstemmed | Evolving therapies for atopic dermatitis: Bridging guidelines and practice |
| title_short | Evolving therapies for atopic dermatitis: Bridging guidelines and practice |
| title_sort | evolving therapies for atopic dermatitis bridging guidelines and practice |
| url | https://annals.edu.sg/evolving-therapies-for-atopic-dermatitis-bridging-guidelines-and-practice/ |
| work_keys_str_mv | AT pawineererknimitr evolvingtherapiesforatopicdermatitisbridgingguidelinesandpractice |